This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: The Innovations of Peter H Crackett
Introduction
Peter H Crackett is a notable inventor based in Baldock, GB. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on triazine derivatives. His research focuses on compounds that possess xanthine oxidase inhibiting activity, which can be utilized as medicaments for the control or prevention of ischemia or gout.
Latest Patents
Peter H Crackett holds a patent for triazine derivatives, specifically compounds of the formula ##STR1## wherein A represents a grouping of the formula ##STR2##. These compounds include various substituents such as hydrogen, halogen, trifluoromethyl, nitro, amino, and several others. The patent highlights the potential of these compounds to be manufactured using known methods and their application in pharmaceutical formulations.
Career Highlights
Throughout his career, Peter H Crackett has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic applications, showcasing his expertise in the field.
Collaborations
Peter has collaborated with notable colleagues such as Michael Richard Attwood and Geoffrey Lawton. These collaborations have further enriched his research and innovation in medicinal chemistry.
Conclusion
Peter H Crackett's contributions to the field of medicinal chemistry through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of new therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
